Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia

por Cortelezzi, Agostino, Sciumè, Mariarita, Reda, Gianluigi
Publicado 2012

The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia

por Noto, Alessandro, Cassin, Ramona, Mattiello, Veronica, Reda, Gianluigi
Publicado 2021

Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?

por Noto, Alessandro, Cassin, Ramona, Mattiello, Veronica, Bortolotti, Marta, Reda, Gianluigi, Barcellini, Wilma
Publicado 2023

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study

por Reda, Gianluigi, Fattizzo, Bruno, Cassin, Ramona, Mattiello, Veronica, Tonella, Tatiana, Giannarelli, Diana, Massari, Ferdinando, Cortelezzi, Agostino
Publicado 2018

Off-Label Use of Thrombopoietin Receptor Agonists: Case Series and Review of the Literature

por Capecchi, Marco, Serpenti, Fabio, Giannotta, Juri, Pettine, Loredana, Reda, Gianluigi, Martinelli, Ida, Artoni, Andrea, Barcellini, Wilma, Fattizzo, Bruno
Publicado 2021

Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine

por Pescia, Carlo, Boggio, Francesca, Croci, Giorgio Alberto, Cassin, Ramona, Barella, Marco, Pettine, Loredana, Reda, Gianluigi, Sabattini, Elena, Finelli, Carlo, Gianelli, Umberto
Publicado 2021

Reply to “CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report” Analysis of six hematological centers in Lombardy: On behalf of CLL commission of Lombardy Hemato...

por Reda, Gianluigi, Noto, Alessandro, Cassin, Ramona, Zamprogna, Giulia, Borella, Chiara, Scarfò, Lydia, Farina, Lucia, Molteni, Alfredo, Ghia, Paolo, Tedeschi, Alessandra, Montillo, Marco
Publicado 2020

FZD6 triggers Wnt–signalling driven by WNT10B(IVS1) expression and highlights new targets in T‐cell acute lymphoblastic leukemia

por Cassaro, Adriana, Grillo, Giovanni, Notaro, Marco, Gliozzo, Jessica, Esposito, Ilaria, Reda, Gianluigi, Trojani, Alessandra, Valentini, Giorgio, Di Camillo, Barbara, Cairoli, Roberto, Beghini, Alessandro
Publicado 2021

Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes

por Santini, Valeria, Girelli, Domenico, Sanna, Alessandro, Martinelli, Nicola, Duca, Lorena, Campostrini, Natascia, Cortelezzi, Agostino, Corbella, Michela, Bosi, Alberto, Reda, Gianluigi, Olivieri, Oliviero, Cappellini, Maria Domenica
Publicado 2011

Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pa...

por Tedeschi, Alessandra, Innocenti, Idanna, Albano, Francesco, Gozzetti, Alessandro, Levato, Luciano, Porrazzo, Marika, Reda, Gianluigi, Albi, Elisa, Chiarenza, Annalisa, Gualberti, Giuliana, Malgieri, Simona, Finsinger, Paola, Trentin, Livio
Publicado 2021

Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study

por Lessi, Federica, Laurino, Marica, Papayannidis, Cristina, Vitagliano, Orsola, Grimaldi, Francesco, Lazzarotto, Davide, Gottardi, Michele, Crisà, Elena, Riva, Marta, Reda, Gianluigi, Ermani, Mario, Semenzato, Gianpietro, Trentin, Livio, Ferrara, Felicetto
Publicado 2021

Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort

por Reda, Gianluigi, Mattiello, Veronica, Frustaci, Anna Maria, Visentin, Andrea, Mauro, Francesca Romana, Innocenti, Idanna, Gentile, Massimo, Giannarelli, Diana, Noto, Alessandro, Cassin, Ramona, Neri, Antonino, Laurenti, Luca, Tedeschi, Alessandra
Publicado 2022

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi

por Zamprogna, Giulia, Frustaci, Anna Maria, Travi, Giovanna, Borella, Chiara, Reda, Gianluigi, Motta, Marina, Deodato, Marina, Bossi, Elisa, Mattiello, Veronica, Ferrari, Maria Beatrice, Cotilli, Giulia, Gambacorti-Passerini, Carlo, Cairoli, Roberto, Puoti, Massimo, Tedeschi, Alessandra
Publicado 2023

Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study

por Bucelli, Cristina, Fattizzo, Bruno, Cattaneo, Daniele, Giannotta, Juri Alessandro, Barbullushi, Kordelia, Pasquale, Raffaella, Barozzi, Enrico, Barbanti, Maria Chiara, Pettine, Loredana, Rossi, Francesca Gaia, Reda, Gianluigi, Cassin, Ramona, Barcellini, Wilma, Baldini, Luca, Iurlo, Alessandra
Publicado 2021

TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia

por Puzzolo, Maria Cristina, Del Giudice, Ilaria, Peragine, Nadia, Mariglia, Paola, De Propris, Maria Stefania, Cappelli, Luca Vincenzo, Trentin, Livio, Reda, Gianluigi, Cuneo, Antonio, Molica, Stefano, Piciocchi, Alfonso, Arena, Valentina, Mauro, Francesca Romana, Guarini, Anna, Foà, Robin
Publicado 2021

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report

por Cuneo, Antonio, Scarfò, Lydia, Reda, Gianluigi, Varettoni, Marzia, Quaglia, Francesca Maria, Marchetti, Monia, De Paoli, Lorenzo, Re, Francesca, Pietrasanta, Daniela, Rigolin, Gian Matteo, Orsucci, Lorella, Ibatici, Adalberto, Gattei, Valter, Mauro, Francesca R., Trentin, Livio, Laurenti, Luca, Marasca, Roberto, Foà, Robin
Publicado 2020

Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)

por Oliva, Esther Natalie, Candoni, Anna, Salutari, Prassede, Palumbo, Giuseppe A., Reda, Gianluigi, Iannì, Giuseppe, Tripepi, Giovanni, Cuzzola, Maria, Capelli, Debora, Mammì, Corrado, Alati, Caterina, Cannatà, Maria Concetta, Niscola, Pasquale, Serio, Bianca, Musto, Pellegrino, Vigna, Ernesto, Volpe, Antonio, Melillo, Lorella Maria Antonia, Arcadi, Maria Teresa, Mannina, Donato, Zannier, Maria Elena, Latagliata, Roberto
Publicado 2023

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study

por Mauro, Francesca R., Giannarelli, Diana, Galluzzo, Clementina M., Visentin, Andrea, Frustaci, Anna M., Sportoletti, Paolo, Vitale, Candida, Reda, Gianluigi, Gentile, Massimo, Levato, Luciano, Murru, Roberta, Armiento, Daniele, Molinari, Maria C., Proietti, Giulia, Pepe, Sara, De Falco, Filomena, Mattiello, Veronica, Barabino, Luca, Amici, Roberta, Coscia, Marta, Tedeschi, Alessandra, Girmenia, Corrado, Trentin, Livio, Baroncelli, Silvia
Publicado 2023

Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study

por Visentin, Andrea, Mauro, Francesca Romana, Catania, Gioachino, Fresa, Alberto, Vitale, Candida, Sanna, Alessandro, Mattiello, Veronica, Cibien, Francesca, Sportoletti, Paolo, Gentile, Massimo, Rigolin, Gian Matteo, Quaglia, Francesca Maria, Murru, Roberta, Gozzetti, Alessandro, Molica, Stefano, Marchetti, Monia, Pravato, Stefano, Angotzi, Francesco, Cellini, Alessandro, Scarfò, Lydia, Reda, Gianluigi, Coscia, Marta, Laurenti, Luca, Ghia, Paolo, Foà, Robin, Cuneo, Antonio, Trentin, Livio
Publicado 2022

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study

por Bomben, Riccardo, Rossi, Francesca Maria, Vit, Filippo, Bittolo, Tamara, Zucchetto, Antonella, Papotti, Robel, Tissino, Erika, Pozzo, Federico, Degan, Massimo, Polesel, Jerry, Bulian, Pietro, Marasca, Roberto, Reda, Gianluigi, Laurenti, Luca, Olivieri, Jacopo, Chiarenza, Annalisa, Laureana, Roberta, Postorino, Massimiliano, Del Principe, Maria Ilaria, Cuneo, Antonio, Gentile, Massimo, Morabito, Fortunato, Fronza, Gilberto, Tafuri, Agostino, Zaja, Francesco, Foà, Robin, Di Raimondo, Francesco, Del Poeta, Giovanni, Gattei, Valter
Publicado 2023